✦ LIBER ✦

VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults

✍ Scribed by Morra, E.; Lazzarino, M.; Alessandrino, E.P.; Inverardi, D.; Canevari, A.; Bernasconi, C.

Book ID: 122032156
Publisher: Elsevier Science
Year: 1984
Weight: 490 KB
Volume: 20
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(84)90138-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide (VP-16) and cytosine-arabinosi

Etoposide (VP-16) and cytosine-arabinoside (ARA-C) combination for secondary and relapsed acute myeloid leukemia (AML)

✍ M. Lazzarino; E. Morra; D. Inverardi; E.P. Alessandrino; P. Bernasconi; S. Meran 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Daunorubicin, cytosine arabinoside, 6-me

Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults

✍ Ryuzo Ohno; Masami Hirano; Kuniyuki Imai; Katsuo Koie; Tadashi Kamiya; Hiroshi N 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Daunorubicin, cytosine arabinoside, 6-me

Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults

✍ Ryuzo Ohno; Masami Hirano; Kuniyuki Imai; Katsuo Koie; Tadashi Kamiya; Hiroshi N 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Idarubicin in sequential combination wit

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia

✍ Lambertenghi-Deliliers, Giorgio; Maiolo, Anna Teresa; Annaloro, Claudio; Cortele 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 515 KB

A four-year experience with anthracyclin

A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia

✍ Dr. M. J. Keating; T. L. Smith; K. B. McCredie; G. P. Bodey; E. M. Hersh; J. U. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 996 KB

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study

✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas Büc 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru